GAAPP World COPD Day 2022

Speak up for COPD

We want you to lend your voice to help us spread the word and Speak-Up for COPD.

GAAPP has prepared an easy-to-use social media assets toolkit for your organization to share in your social media channels (Facebook, Twitter, Instagram, and LinkedIn.), website, and newsletters.

Please help us spread the word!

About the #SpeakUpforCOPD campaign

We have one critical goal: to increase the awareness and understanding of COPD amongst policymakers and healthcare decision-makers.

Why do we need to Speak Up for COPD?

• COPD affects approximately 384 million people⁴ around the world and is the third leading cause of death⁵
• 1 in 5 people will die within a year of their first COPD hospitalisation.⁶

• Despite the huge burden and the fact that survival from COPD is comparable to some cancers, no one talks about it.^7-9 As a result, COPD is under-prioritised, underfunded, and undertreated.^10-13
• The global cost of COPD is estimated to rise to US $4.8 trillion in 2030¹⁴but it does not receive the political attention or funding proportionate to its population and societal burden.¹³
• The world can no longer afford to overlook COPD. We need greater recognition of the impact of COPD on individuals and society to ensure people living with this disease receive the care they need and deserve.

GAAPP World COPD Day 2022 Campaign has been made possible thanks to the generous support from our partners:

The Speak up for COPD assets and campaign provided by the Speak Up for COPD campaign has been funded by AstraZeneca with support from Chiesi Farmaceutici, the International Federation on Ageing and the Global Allergy and Airways Patient Platform for awareness purposes only. It should not be used for diagnosing or treating a health problem or disease. If you have any questions about your medical condition, talk to a healthcare professional.

References:

1. WHO. Chronic obstructive pulmonary disease (COPD). Available https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Last accessed: 9 May 2022.
2. Global Allergy & Airways Patient Platform. Available at: http://gaapp.org/copd/what-is-copd/.
3. Kim et al. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. European Respiratory Journal (2018 52: 1801261).
4. GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2022. [Online]. Available at: https://goldcopd.org/2022-gold-reports-2
5. WHO Fact Sheet; The Top 10 Causes of Death https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
6. Ho et al. In-Hospital and One-Year Mortality and Their Predictors in Patients Hospitalized for First-Ever Chronic Obstructive Pulmonary Disease Exacerbations: A Nationwide Population-Based Study.A Nationwide Population-Based Study. PLOS ONE 9(12)
7. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis. 2009;4:137-48. https://pubmed.ncbi.nlm.nih.gov/19436692/
8. Five-year cancer survival rate, measured as the percentage of people who survive at least five years since diagnosis. Our World in Data: https://ourworldindata.org/grapher/five-year-cancer-survival-in-usa?time=1977..2013&country=~All+races%2C+total. Sourced by NCI.
9. Nuffield Trust: Cancer survival rates; https://www.nuffieldtrust.org.uk/resource/cancer-survival-rates?gclid=EAIaIQobChMI0LiC7ZSZ-QIVEb_tCh32iwXrEAAYAiAAEgKvn_D_BwE#background
10.  Yorgancioglu A, Khaltaev N, Bousquet J, Varghese C. The Global Alliance Against Chronic Respiratory Diseases: journey so far and way ahead. Chinese Medical Journal. 2020; 133: 1513–1515. doi: 10.1097/CM9.0000000000000851.
11. Ballreich et al. Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019. JAMA Network Open. 2021; 4(1): e2034890.
12. Make B, Dutro MP, Paulose-Ram R, Marton JP, Mapel DW. Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients. International Journal of Chronic Obstructive Pulmonary Disease. 2012; 7: 1.
13. Quaderi, S. A., & Hurst, J. R. (2018). The unmet global burden of COPD. Global health, epidemiology, and genomics, 3, e4.
14. Bloom DE, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum; 2011. Available at: https://world-heart-federation.org/wp-content/uploads/2017/05/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf. [Last accessed: May 2022].